Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2010 Jun 15;33(6):361–366. doi: 10.1002/clc.20768

QT Prolongation Is an Independent Predictor of Mortality in End‐Stage Renal Disease

Fadi G Hage 1,2,✉, Angelo M de Mattos 3, Hasan Khamash 4, Shikha Mehta 4, David Warnock 4, Ami E Iskandrian 1
PMCID: PMC6653199  PMID: 20556806

Abstract

Background

Coronary artery disease (CAD) is the predominant cause of sudden cardiac death in the general population, and sudden cardiac death is the leading cause of mortality in end‐stage renal disease (ESRD).

Hypothesis

QT‐interval prolongation is an independent prognosticator in ESRD.

Methods

We reviewed clinical, electrocardiographic, stress test, and coronary angiography data on ESRD patients evaluated for transplantation at our institution between 2000 and 2004 who underwent coronary angiography. The QT interval was corrected for heart rate and QRS duration (QTc). All‐cause mortality data were prospectively collected and verified against the Social Security Death Index database.

Results

During 40 ± 28 months of follow‐up, 132 of the 280 (47%) patients died prior to renal transplantation. Patients with a prolonged QTc (39%) had 1‐, 3‐, and 5‐year death‐rates of 12%, 36%, and 47%, respectively, vs 8%, 24%, and 36% for those with normal QTc (log‐rank P = 0.03). In a multivariate Cox regression model that adjusted for age, gender, diabetes mellitus, myocardial infarction, presence and severity of CAD on angiography, left ventricular (LV) hypertrophy, LV ejection fraction (EF), and multiple other variables, QTc remained to be an independent predictor of survival (hazard ratio [HR]: 1.008, 95% confidence interval [CI]: 1.001–1.014, P = 0.016). Female gender, decreasing LVEF, and decreasing severity of CAD on angiography were independent predictors of prolonged QTc.

Conclusions

QTc prolongation is an independent predictor of mortality in ESRD patients being evaluated for renal transplantation. The prognostic information gained from the QTc is additive to that provided by the LVEF and the severity of CAD. Copyright © 2010 Wiley Periodicals, Inc.

Full Text

The Full Text of this article is available as a PDF (241.5 KB).

References

  • 1. Hage FG, Venkataraman R, Zoghbi GJ, Perry GJ, de Mattos AM, Iskandrian AE. The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol 2009; 53: 2129–2140. [DOI] [PubMed] [Google Scholar]
  • 2. Lindner A, Charra B, Sherrard DJ, et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697–701. [DOI] [PubMed] [Google Scholar]
  • 3. US Renal Data System. USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End‐Stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 2007. [Google Scholar]
  • 4. Herzog CA, Mangrum JM, Passman R. Sudden cardiac death and dialysis patients. Semin Dial 2008; 21: 300–307. [DOI] [PubMed] [Google Scholar]
  • 5. Myerburg RJ, Castellanos A. Emerging paradigms of the epidemiology and demographics of sudden cardiac arrest. Heart Rhythm 2006; 3: 235–239. [DOI] [PubMed] [Google Scholar]
  • 6. Hage FG, Smalheiser S, Zoghbi GJ, et al. Predictors of survival in patients with end‐stage renal disease evaluated for kidney transplantation. Am J Cardiol 2007; 100: 1020–1025. [DOI] [PubMed] [Google Scholar]
  • 7. Venkataraman R, Hage FG, Dorfman T, et al. Role of myocardial perfusion imaging in patients with end‐stage renal disease undergoing coronary angiography. Am J Cardiol 2008; 102: 1451–1456. [DOI] [PubMed] [Google Scholar]
  • 8. Venkataraman R, Hage FG, Dorfman TA, et al. Relation between heart rate response to adenosine and mortality in patients with end‐stage renal disease. Am J Cardiol 2009; 103: 1159–1164. [DOI] [PubMed] [Google Scholar]
  • 9. Hancock EW, Deal BJ, Mirvis DM, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009; 53: 992–1002. [DOI] [PubMed] [Google Scholar]
  • 10. Rautaharju PM, Zhang ZM, Prineas R, Heiss G. Assessment of prolonged QT and JT intervals in ventricular conduction defects. Am J Cardiol 2004; 93: 1017–1021. [DOI] [PubMed] [Google Scholar]
  • 11. Surawicz B, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009; 53: 976–981. [DOI] [PubMed] [Google Scholar]
  • 12. Rautaharju PM, Surawicz B, Gettes LS, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009; 53: 982–991. [DOI] [PubMed] [Google Scholar]
  • 13. Germano G, Kavanagh PB, Berman DS. An automatic approach to the analysis, quantitation and review of perfusion and function from myocardial perfusion SPECT images. Int J Card Imaging 1997; 13: 337–346. [DOI] [PubMed] [Google Scholar]
  • 14. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device‐Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 51: e1–e62. [DOI] [PubMed] [Google Scholar]
  • 15. De Mattos AM, Siedlecki A, Gaston RS, et al. Systolic dysfunction portends increased mortality among those waiting for renal transplant. J Am Soc Nephrol 2008; 19: 1191–1196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Cheng S, Keyes MJ, Larson MG, et al. Long‐term outcomes in individuals with prolonged PR interval or first‐degree atrioventricular block. JAMA 2009; 301: 2571–2577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Oikarinen L, Nieminen MS, Viitasalo M, et al; for LIFE Study Investigators. QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 2004; 43: 1029–1034. [DOI] [PubMed] [Google Scholar]
  • 18. Vrtovec B, Delgado R, Zewail A, Thomas CD, Richartz BM, Radovancevic B. Prolonged QTc interval and high B‐type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation 2003; 107: 1764–1769. [DOI] [PubMed] [Google Scholar]
  • 19. Iuliano S, Fisher SG, Karasik PE, et al. QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002; 143: 1085–1091. [DOI] [PubMed] [Google Scholar]
  • 20. Elhendy A, Hammill SC, Mahoney DW, et al. Relation of QRS duration on the surface 12‐lead electrocardiogram with mortality in patients with known or suspected coronary artery disease. Am J Cardiol 2005; 96: 1082–1088. [DOI] [PubMed] [Google Scholar]
  • 21. Stewart GA, Gansevoort RT, Mark PB, et al. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int 2005; 67: 217–226. [DOI] [PubMed] [Google Scholar]
  • 22. Suzuki R, Tsumura K, Inoue T, et al. QT interval prolongation in the patients receiving maintenance hemodialysis. Clin Nephrol 1998; 49: 240–244. [PubMed] [Google Scholar]
  • 23. Voiculescu M, Ionescu C, Ismail G. Frequency and prognostic significance of QT prolongation in chronic renal failure patients. Rom J Intern Med 2006; 44: 407–417. [PubMed] [Google Scholar]
  • 24. Singh JP, Sleight P, Kardos A, et al. QT interval dynamics and heart rate variability preceding a case of cardiac arrest. Heart 1997; 77: 375–377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Patanè S, Marte F, Di Bella G, et al. QT interval prolongation, torsade de pointes and renal disease. Int J Cardiol 2008; 130: e71–e73. [DOI] [PubMed] [Google Scholar]
  • 26. Beaubien ER, Pylypchuk GB, Akhtar J, et al. Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality. Am J Kidney Dis 2002; 39: 834–842. [DOI] [PubMed] [Google Scholar]
  • 27. Yildiz A, Akkaya V, Tükek T, et al. Increased QT dispersion in hemodialysis patients improve after renal transplantation: a prospective‐controlled study. Transplantation 2001; 72: 1523–1526. [DOI] [PubMed] [Google Scholar]
  • 28. Covic A, Diaconita M, Gusbeth‐Tatomir P, et al. Haemodialysis increases QT(c) interval but not QT(c) dispersion in ESRD patients without manifest cardiac disease. Nephrol Dial Transplant 2002; 17: 2170–2177. [DOI] [PubMed] [Google Scholar]
  • 29. Lörincz I, Zilahi Z, Kun C, et al. ECG abnormalities in hemodialysis. Am Heart J 1997; 134: 1138–1140. [DOI] [PubMed] [Google Scholar]
  • 30. Kang YJ. Cardiac hypertrophy: a risk factor for QT‐prolongation and cardiac sudden death. Toxicol Pathol 2006; 34: 58–66. [DOI] [PubMed] [Google Scholar]
  • 31. Sohaib SM, Papacosta O, Morris RW, Macfarlane PW, Whincup PH. Length of the QT interval: determinants and prognostic implications in a population‐based prospective study of older men. J Electrocardiol 2008; 41: 704–710. [DOI] [PubMed] [Google Scholar]
  • 32. Maeda T, Saikawa T, Niwa H, et al. QT interval shortening and ST elevation in intracoronary ECG during PTCA. Clin Cardiol 1992; 15: 525–528. [DOI] [PubMed] [Google Scholar]
  • 33. Gottlieb SS. Dead is dead—artificial definitions are no substitute. Lancet 1997; 349: 662–663. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES